Syneos Health and Aetion Partner to Offer RWE Solutions


Syneos Health and Aetion announced a partnership to provide regulatory-grade data and analytics-driven solutions to advance drug development and improve patient outcomes.

The partnership brings together Syneos Health’s proprietary data collection and research solutions with Aetion Evidence Platform (AEP) to generate evidence through patient data curation and real-world data.

Syneos Health’s offerings, including its Biopharmaceutical Acceleration Model, Dynamic Assembly, and RWE Solutions, enable biopharmaceutical companies to accelerate product development and patient access to new therapies; reduce risk through evidence-based decision-making; and demonstrate value to a broad healthcare ecosystem, including patients, regulators, payers, and health care providers. Aetion’s AEP analyzes data from the real world—including claims, electronic health records, registries, and clinical trial data—to produce transparent, rapid, and scientifically validated real-world evidence on the safety, effectiveness, and value of medical interventions.

Read more about the partnership here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.